Mapping the evolutionary landscape of intestinal organoids: from self-organization biology to precision medicine Authors: Fengni Liang, Zerong Pei, Xuemei Wang, Ke Zhang Published: 2026 ABSTRACT The advent of intestinal organoids has fundamentally transformed biomedical research by providing a physiological ex vivo model that recapitulates native tissue architecture. Despite an exponential surge in publications, a comprehensive mapping of the field’s evolutionary trajectory remains lacking. This study employs bibliometric analysis to dissect the global landscape of intestinal organoid research from 1986 to 2025, utilizing data from the Web of Science Core Collection. By leveraging VOSviewer and bibliometrix tools, we demonstrate that while the USA dominates in publication quantity, the Netherlands commands the highest citation influence, reflecting the enduring legacy of foundational works by Sato and Clevers. Co-citation and keyword trend analyses demonstrate evolving research priorities. The field initially focused on stem cell differentiation and culture optimization, then expanded into disease modeling of colorectal cancer and inflammatory bowel disease. Notably, recent burst detection identifies a clear pivot towards “organ-on-a-chip” technology, “mechanobiology,” and “single-cell sequencing”. These hotspots signal the advent of precision engineering. Bioengineering and high-throughput omics together drive the development of next-generation physiologically relevant intestinal models. Ideally, this bibliometric blueprint serves as a navigational guide for researchers, highlighting the paradigm shift towards complex, engineered micro-physiological systems (MPS) as the future of intestinal research. Introduction The mammalian intestine is a highly complex organ characterized by a distinct crypt-villus architecture, diverse cell types, and intricate interactions with the gut microbiota and immune system [1]. Historically, our understanding of intestinal physiology and pathology—such as inflammatory bowel disease (IBD) and colorectal cancer (CRC)—relied heavily on two-dimensional (2D) cancer cell lines (e.g., Caco-2) and animal models [2]. These conventional experimental models have clear limitations. 2D culture systems cannot replicate the structural and functional complexity of intestinal epithelium, and murine models show species disparities that hinder clinical translation [3, 4]. The landscape of intestinal research was fundamentally transformed in 2009 with the landmark discovery by Sato and Clevers [5]. By identifying Lgr5 + stem cells and defining the specific niche factors required for their maintenance, they successfully established the first long-term culture system for intestinal organoids. These self-organizing, three-dimensional (3D) structures faithfully mirror the genetic signatures, cellular heterogeneity, and physiological functions of the tissue of origin. Over the past decade, intestinal organoids have evolved from a developmental biology curiosity into a cornerstone of biomedical research, widely applied in modeling host-pathogen interactions, rapid drug screening, and personalized regenerative medicine [6, 7]. Following this technological breakthrough, the field has experienced an information explosion. The volume of publications regarding intestinal organoids has grown exponentially, expanding into diverse sub-disciplines including bioengineering, virology (e.g., SARS-CoV-2 studies), and immunology [8, 9]. Existing narrative reviews tend to focus on limited research subfields and are susceptible to subjective selection bias. Accordingly, it is difficult for researchers, especially newcomers, to clarify global research evolution, identify key contributors, and distinguish emerging frontiers from established knowledge. Bibliometrics is a statistical method used to analyze academic literature quantitatively. Unlike comprehensive reviews, bibliometric analysis utilizes mathematical tools to map the knowledge structure of a scientific domain objectively. By visualizing citation networks, keyword co-occurrence and research collaboration patterns, researchers can clarify research trends and identify research bursts with promising future prospects [10]. Although intestinal organoid technology has matured, a comprehensive bibliometric evaluation of its global development is lacking. In this study, we retrieved emerging literature from the Web of Science Core Collection (WoSCC) spanning from 1986 to 2025. Using advanced visualization tools (VOSviewer, CiteSpace, and Bibliometrix), we conducted a multi-dimensional analysis to: (1) Outline the global distribution of research forces (countries, institutions, and authors); (2) Identify the intellectual base through landmark citations; and (3) Uncover the temporal evolution of research hotspots—from initial culture establishment to the current era of “organ-on-a-chip” and multi-omics precision medicine. This study provides a panoramic guide for researchers to understand the past, seize the present, and anticipate the future of intestinal organoid research. Source of the data and search strategy Research methods The bibliometric analysis offers pertinent information, including authors, keywords, journals, countries, institutions, and references, during the analytical process. This analysis facilitates a more effective screening of specific research within the domains of distinguished research teams, research institutions, and appropriate journals for publication [11]. Data analysis software, including VOSviewer (version 1.6.16), Citespace (version 5.8.R3), Biblioshiny (an open-source online visualization software based on Rstudio), and Origin 2021, have been used for visual representation and in-depth mining of data [12]. Visual analysis provides insights into the popularity of research and the evolution of trending keywords over time. Additionally, the examination of co-citation, co-authorship, and co-occurrence enhances our understanding of the collaborative relationships among various countries, institutions, authors, and journals [13]. Data source In this paper, the Web of Science was selected as the data source. To ensure comprehensive and accurate retrieval, the Science Citation Index Expanded and the Social Sciences Citation Index were included. We used an advanced search with the query (TS= (Intestinal organoids)). The search spanned Jan 1986 to Dec 2025, and the cutoff date was Jan 10, 2026. A total of 3177 valid journal papers were obtained. Results Analysis of publication outputs and trends A total of 3177 publications related to intestinal organoids were retrieved. As shown in Fig. 1A, regarding publication types, original research Articles constituted the significant majority of the dataset, accounting for 74.86% of the total documents. Review Articles ranked second (14.24%), followed by Meeting Abstracts (7.16%). This distribution indicates that original experimental research is the primary driver of knowledge expansion in this field. The subject category analysis (Fig. 1B) underscores the multidisciplinary nature of this field. “Cell Biology” ranks first, confirming that intestinal organoids function primarily as physiologically relevant models to study basic cellular mechanisms, bridging the gap between 2D cell lines and animal models. Notably, “Gastroenterology & Hepatology” holds a prominent position. This distribution is consistent with the historical development of the technology, which originated from the gut and liver systems [14]. Furthermore, the substantial presence of “Oncology” indicates a growing trend towards translational application, particularly in the use of Patient-Derived intestinal organoids for drug screening and personalized medicine [15]. The temporal evolution of scientific output is depicted in Fig. 1C. The trajectory can be roughly divided into two phases. Before 2011, the annual publication count remained at a relatively low basal level. However, a turning point appeared around 2011–2012, after which intestinal organoids research entered a phase of exponential growth. The annual output soared from fewer than 20 papers in 2011 to over 400 in recent years (2024–2025). The publication trend remained relatively flat prior to 2010 but exhibited an inflection point around 2011–2012. This “explosion” of interest correlates directly with seminal milestones in stem cell biology. Specifically, the establishment of the Lgr5 + intestinal organoids culture system by Sato and Clevers in 2009 and 2011 demonstrated for the first time that adult stem cells could self-organize into functional 3D structures in vitro [5, 16]. Subsequently, the development of cerebral organoids [17] and optic cup organoids [18] further fueled the exponential growth seen in our data, expanding the technology from gastroenterology to neuroscience and developmental biology. The cumulative number of publications (red line) highlights a robust and continuous upward trend, indicating that intestinal organoid technology has garnered increasing attention from the global scientific community over the past decade. Fig. 1Overview of scientific output on intestinal organoid research. (A) The distribution of document types among the retrieved publications. “Article” is the predominant type. (B) Radar chart showing the top subject categories involved in intestinal organoid research. (C) Annual and cumulative numbers of publications from 1986 to 2025. The dual-axis chart displays the annual output (bars, left axis) and the cumulative total (line, right axis) Overview of scientific output on intestinal organoid research. (A) The distribution of document types among the retrieved publications. “Article” is the predominant type. (B) Radar chart showing the top subject categories involved in intestinal organoid research. (C) Annual and cumulative numbers of publications from 1986 to 2025. The dual-axis chart displays the annual output (bars, left axis) and the cumulative total (line, right axis) Contribution and impact of leading countries/regions The global research landscape of intestinal organoids is characterized by a distinct hierarchy in both productivity and impact. As summarized in Table 1; Fig. 2A-B, the USA is the undisputed leader, ranking first in all primary metrics, including total publication count (1,131), total citations (64,643), and H-index (116). This hegemony reflects the country’s mature funding mechanisms and established research infrastructure in stem cell biology. However, a deeper cross-examination of Table 1 reveals a remarkable divergence between output volume and citation impact. While the Netherlands ranks third in quantity (402 papers), it commands the highest average citation per paper (99.11), approximately 1.7-fold higher than that of the that of the global average and significantly surpassing the USA (57.16). Switzerland (Rank 10) similarly demonstrates high efficiency with an average citation of 72.28. This “Dutch Phenomenon”—high impact with moderate volume—is historically attributable to the genesis of the field. The Hubrecht Institute in the Netherlands, home to Hans Clevers and colleagues, pioneered the Lgr5 + intestinal organoid culture system [5, 16]. These foundational “landmark papers” continue to drive massive citations, elevating the national impact metrics. The temporal analysis (Fig. 2C) highlights the evolving momentum of the field. Following the technological breakthroughs around 2011, the global output surged. Notably, China has exhibited the steepest growth trajectory over the past decade, securing the second position in total productivity (616 papers). Despite this rapid quantitative expansion, China’s average citation rate (23.53) remains lower compared to Western counterparts. This pattern is typical for rapidly emerging scientific powers, where volume growth often precedes impact accumulation. The apparent decline in total citations for 2024–2025 (Fig. 2C, black line) does not indicate waning interest but rather reflects a clear citation time-lag, as recently published works have yet to accrue their full citation potential. International collaboration is pivotal for calculating the global flow of knowledge. The Chord diagram (Fig. 2D) and Network map (Fig. 2E) visualize a dense global network with the USA acting as the central hub (Highest Total Link Strength, TLS = 748). Quantitative analysis of collaboration types using the Multiple Country Publication (MCP) ratio in Table 1 reveals distinct regional strategies: European and North American countries demonstrate a strong propensity for cross-border research. The Netherlands (MCP Ratio: 29.10%), Canada (25.78%), and Germany (25.23%) have the highest proportions of internationally co-authored papers, suggesting an open and highly integrated research ecosystem. In contrast, East Asian leaders show lower MCP ratios, such as China (16.23%), Japan (11.73%), and South Korea (10.57%). This indicates that research in these regions is currently more reliant on domestic networks (Single Country Publications, SCP). While the USA acts as a global connector, the high MCP ratios in Europe likely reflect EU-wide funding initiatives (e.g., Horizon Europe) that mandate multi-national consortiums. Increasing the MCP ratio could be a strategic direction for Asian countries to further enhance their global influence and citation impact. Table 1Top 10 productive countries/regions related to intestinal organoidsRankCountryCountsH-indexSCPMCPMCP-RatioTLSTotal citationsAverage citation per paper1.USA113111691421719.1974864,64357.162.China6165651610016.2326514,49623.533.Netherlands4028028511729.1044239,84299.114.Germany333632498425.2339513,18239.595.Japan307582713611.7320317,72157.726.UK291652197224.7435914,72050.587.France146351123423.29177574639.368.Canada12835953325.78190584745.689.South Korea123311101310.5759323926.3310.Switzerland12244972520.49202881872.28 Table 1Top 10 productive countries/regions related to intestinal organoidsRankCountryCountsH-indexSCPMCPMCP-RatioTLSTotal citationsAverage citation per paper1.USA113111691421719.1974864,64357.162.China6165651610016.2326514,49623.533.Netherlands4028028511729.1044239,84299.114.Germany333632498425.2339513,18239.595.Japan307582713611.7320317,72157.726.UK291652197224.7435914,72050.587.France146351123423.29177574639.368.Canada12835953325.78190584745.689.South Korea123311101310.5759323926.3310.Switzerland12244972520.49202881872.28 Top 10 productive countries/regions related to intestinal organoids Fig. 2Global geographic distribution and international cooperation analysis of intestinal organoid research. A World map visualizing the productivity and impact of the top performing countries. The color intensity represents the total publication count, while bubble size and color indicate average citations and H-index, respectively. B The top 10 most productive countries ranked by publication count, with a pie chart showing the percentage share of global output. C Annual publication trends of the top 5 countries (bars, left axis) and total annual citation counts (line, right axis). D Chord diagram depicting the volume of collaborative publications between countries. The width of the connecting bands represents the number of co-authored papers. E Collaborative network map. Nodes represent countries, and node size correlates with publication volume. The thickness of the connecting lines indicates the strength of collaboration Global geographic distribution and international cooperation analysis of intestinal organoid research. A World map visualizing the productivity and impact of the top performing countries. The color intensity represents the total publication count, while bubble size and color indicate average citations and H-index, respectively. B The top 10 most productive countries ranked by publication count, with a pie chart showing the percentage share of global output. C Annual publication trends of the top 5 countries (bars, left axis) and total annual citation counts (line, right axis). D Chord diagram depicting the volume of collaborative publications between countries. The width of the connecting bands represents the number of co-authored papers. E Collaborative network map. Nodes represent countries, and node size correlates with publication volume. The thickness of the connecting lines indicates the strength of collaboration Institutional productivity and research micro-ecosystems An analysis of the top performing institutions represents a highly skewed distribution of scientific output. As delineated in Table 2 and visualized in Fig. 3A, the leading contributors are not evenly distributed globally but are remarkably concentrated in Utrecht, the Netherlands. Utrecht University secures the top rank with 201 publications, accounting for approx. 17.2% of the top-tier output, followed closely by Utrecht University Medical Center (180 papers) and the Hubrecht Institute (109 papers, Rank 4). Collectively, these three institutions—all geographically located within the same Dutch city—form a “super-cluster” of innovation. This institutional density facilitates resource sharing. Figure 3B (Heatmap) further reveals that these Dutch institutions were the earliest active players (showing high intensity as early as 2011–2012), establishing their foundational dominance before other global players entered the arena. While the University of California System (Rank 3) and Harvard University (Rank 5) represent the premier US contributions, a comparison of citation metrics in Fig. 3C unveils a dramatic “quality-quantity” gap. The Hubrecht Institute, despite ranking 4th in total quantity, exhibits an unprecedented Average Citation (AC) of 278.08 per paper, vastly outperforming all other institutions (e.g., Harvard: 85.82; UC System: 70.97). The Hubrecht Institute was the site of the seminal discovery of Lgr5 + stem cell-derived intestinal organoids. The high citations are driven by a few “landmark papers” that defined the protocols used universally today. Thus, while US institutions produce high volume through a decentralized network, the Hubrecht Institute remains the “spiritual home” and highest-impact node of the field. The institutional co-authorship map (Fig. 3D) unravels distinct collaborative modules: Anchored by the Hubrecht Institute, Utrecht University, and INSERM (France, Rank 6). This cluster shows dense internal connections, reflecting strong EU-wide consortiums. The North American Network (Orange/Brown Cluster): Dominated by the University of California System, Harvard, and Cincinnati Children’s Hospital (Rank 8). Notably, Cincinnati Children’s Hospital acts as a crucial bridge, likely due to its specialized focus on pediatric gastrointestinal disorders and developmental biology. Emerging/Industry Clusters (Green/Blue): Segments involving Roche Holding and the University of Tokyo suggest growing cross-sector (academia-industry) partnerships and the rising influence of Asian research centers in translational applications. Table 2The top 10 productive institutions ranked by the numbers of publicationsRankInstitutionsCountsCountryH-indexTLSTotal citationsAverage citation per paper1.Utrecht University201Netherlands6435132,776163.062.Utrecht University Medical Center180Netherlands636932,375179.863.University Of California System110USA4147780770.974.Hubrecht Institute Knaw109Netherlands617430,311278.085.Harvard University108USA44100926985.826.Institut National De La Sante Et De La Recherche Medicale Inserm97France26140412942.577.Harvard University Medical Affiliates92USA40261800587.018.Cincinnati Children S Hospital Medical Center91USA36145858794.369.Helmholtz Association90Germany3266404644.9610.University System Of Ohio88USA34126414247.07 Table 2The top 10 productive institutions ranked by the numbers of publicationsRankInstitutionsCountsCountryH-indexTLSTotal citationsAverage citation per paper1.Utrecht University201Netherlands6435132,776163.062.Utrecht University Medical Center180Netherlands636932,375179.863.University Of California System110USA4147780770.974.Hubrecht Institute Knaw109Netherlands617430,311278.085.Harvard University108USA44100926985.826.Institut National De La Sante Et De La Recherche Medicale Inserm97France26140412942.577.Harvard University Medical Affiliates92USA40261800587.018.Cincinnati Children S Hospital Medical Center91USA36145858794.369.Helmholtz Association90Germany3266404644.9610.University System Of Ohio88USA34126414247.07 The top 10 productive institutions ranked by the numbers of publications Fig. 3Institutional contributions to intestinal organoid research. A The pie chart showing the percentage share of the top 10 most productive institutions. B Annual publication heat map illustrating the temporal activity of top institutions from 1994 to 2025. C Polar chart comparing publication counts (purple bars), H-index (green bars), and average citation per paper (red peaks). Note the exceptional citation impact of the Hubrecht Institute. D Institutional collaboration network visualization generated by CiteSpace. Start nodes represent major hubs; colors indicate different cluster communities (e.g., Red: European cluster; Orange: US cluster) Institutional contributions to intestinal organoid research. A The pie chart showing the percentage share of the top 10 most productive institutions. B Annual publication heat map illustrating the temporal activity of top institutions from 1994 to 2025. C Polar chart comparing publication counts (purple bars), H-index (green bars), and average citation per paper (red peaks). Note the exceptional citation impact of the Hubrecht Institute. D Institutional collaboration network visualization generated by CiteSpace. Start nodes represent major hubs; colors indicate different cluster communities (e.g., Red: European cluster; Orange: US cluster) Intellectual structure: author contributions and research paradigms The trajectory of the field is inextricably linked to its pioneers. As evidenced in Table 3, Hans Clevers (Utrecht University/Hubrecht Institute) maintains an insurmountable lead in productivity (96 papers), H-index (60), and total citations (> 30,000). This quantitative dominance mirrors his qualitative role in establishing the Lgr5 + adult stem cell (ASC)-based intestinal organoid system. Following closely is Toshiro Sato (Keio University, Rank 4), who exhibits the highest average citation per paper (384.21). The authorship network (Fig. 4B, Red Cluster) visually confirms a dense “Mentor-Mentee” lineage. Sato, a former postdoctoral fellow in the Clevers lab, was instrumental in developing the seminal culture conditions [5]. This “Dutch-Japanese axis” forms the backbone of the ASC-derived intestinal organoid field, focusing primarily on tissue regeneration and cancer modeling. A distinct intellectual lineage is observed in the United States, led by Jason R. Spence (University of Michigan, Rank 2) and James M. Wells (Rank 5). Unlike the Clevers group, these researchers specialize in generating intestinal organoids from Pluripotent Stem Cells (iPSCs/ESCs) [19]. This methodological divergence is clearly reflected in the network topology (Fig. 4B, Orange/Yellow Cluster; Fig. 4C). The separation between the Clevers/Sato cluster and the Spence/Wells cluster signifies two fundamental approaches in the field: The ASC approach highlights epithelial homeostasis and patient-derived avatars for biobanking [20]. The PSC approach [19] emphasizes developmental biology, focusing on how mesenchyme and endoderm coordinate to form complex gut structures. The top author list also signals the field’s transition from “technology development” to “disease modeling.” Jeffrey M. Beekman (Rank 3) and Cornelis K. Van Der Ent (Rank 8) figure prominently. Their high ranking is driven by the successful clinical application of intestinal organoids for CF drug screening (the Forskolin swelling assay), marking the first widespread implementation of intestinal organoid-based precision medicine [21, 22]. Mary K. Estes (Baylor College of Medicine, Rank 6) uniquely represents the niche of host-pathogen interactions. Her work notably overcame the historical barrier of cultivating human Norovirus, demonstrating the utility of intestinal organoids in infectious disease research [23]. The temporal mapping of author activity (Fig. 4A) illustrates the sustainability of these research communities. While Hans Clevers and Toshiro Sato display continuous high-impact output across the entire decade (indicated by large, dark-red nodes), the emergence of Jason R. Spence and Sha Huang in recent years (larger nodes towards 2020–2025) suggests a broadening of the field’s leadership and a growing emphasis on developmental and bioengineering applications in the US context. Table 3The top 10 most productive authors related to intestinal organoidsRankAuthorPublicationsH-indexTotal citationsAverage citation per paperInstitutions1.Clevers966030,115313.7Hubrecht Institute (KNAW)2.Spence56295621100.38University of Michigan3.Beekman4525368781.93University Medical Center Utrecht4.Sato432316,521384.21Keio University5.Wells39203929100.74Wageningen University & Research6.Estes3821285675.16Baylor College of Medicine7.Shroyer35196241178.31Baylor College of Medicine8.Van Der Ent3317245074.24University Medical Center Utrecht9.Huang3115181158.42University of Michigan10.Watanabe3016241280.4Tokyo Medical & Dental University Table 3The top 10 most productive authors related to intestinal organoidsRankAuthorPublicationsH-indexTotal citationsAverage citation per paperInstitutions1.Clevers966030,115313.7Hubrecht Institute (KNAW)2.Spence56295621100.38University of Michigan3.Beekman4525368781.93University Medical Center Utrecht4.Sato432316,521384.21Keio University5.Wells39203929100.74Wageningen University & Research6.Estes3821285675.16Baylor College of Medicine7.Shroyer35196241178.31Baylor College of Medicine8.Van Der Ent3317245074.24University Medical Center Utrecht9.Huang3115181158.42University of Michigan10.Watanabe3016241280.4Tokyo Medical & Dental University The top 10 most productive authors related to intestinal organoids Fig. 4Author collaboration and impact analysis. A Timeline view of the top productive authors. Node size represents publication volume; color intensity represents citation impact. B–C Author and Co-authorship network maps Author collaboration and impact analysis. A Timeline view of the top productive authors. Node size represents publication volume; color intensity represents citation impact. B–C Author and Co-authorship network maps Journal distribution and dissemination patterns The distribution of literature in intestinal organoid research strictly adheres to Bradford’s Law of Scattering, which categorizes journals into core, related, and non-related zones based on publication density [24]. As visualized in Fig. 5D, a sharp inflection point confirms that the field is anchored by a highly selective “Core Zone.” Gastroenterology (Rank 1) resides at the apex of this Core Zone, publishing 137 articles with an Impact Factor of 25.1. It serves as the primary repository for high-impact findings, acting as the definitive bridge between basic epithelial biology and clinical gastroenterology. The “Zone 2” (related zone) is populated by high-volume, broad-scope journals such as Scientific Reports and International Journal of Molecular Sciences, reflecting the field’s expansion into general biological applications. As shown in Table 4A, Gastroenterology emerges as the paramount venue for this field, publishing 137 articles with a significant Impact Factor (IF) of 25.1. It serves as the central hub where basic stem cell biology meets clinical hepatogastroenterology. Following this, the field exhibits a bifurcated publishing trend: Journals like Scientific Reports (Rank 2) and International Journal of Molecular Sciences (Rank 3) have seen a surge in volume (heatmap in Fig. 5A and 2020–2024), indicating the commoditization of the technology and its widespread adoption across general biological disciplines. A crucial and counter-intuitive finding in Table 4A is the prominence of JoVE (Journal of Visualized Experiments), which ranks 6th globally with 56 publications. In mature biomedical fields (e.g., standard HeLa cell culture), methodology journals rarely occupy top ranks (Fig. 5B). The unusually high reliance on JoVE in this domain highlights a specific bottleneck: the steep technical barrier of intestinal organoid culture. Culturing Lgr5 + intestinal organoids involve complex 3D Matrigel embedding, precise growth factor cocktails (e.g., Wnt3a, R-spondin1, Noggin), and delicate passage techniques. Text-based protocols are often insufficient for replication [25]. The community’s heavy usage of visual protocols suggests that the field is still grappling with standardization and reproducibility. The analysis of Co-cited Journals (Table 4B) reveals the high-impact foundations of the field. While researchers publish in specialty journals (like Gastroenterology), they cite generalist titans. Nature (10,534 citations) and Science (4,292 citations) occupy the top ranks, reflecting intestinal organoids originated from ground-breaking discoveries in fundamental developmental biology (e.g., the identification of Lgr5 + cells). The alignment of Gastroenterology (Rank 2) and Cell Stem Cell (Rank 6) creates a strong “Basic-Clinical” citations axis. This finding indicates that mastering the “art” of culture remains a prerequisite for entry into this field (Fig. 5E). The Dual-Map Overlay (Fig. 5C) traces the intellectual lineage of the field. A dominant citations path flows from the “Molecular, Biology, Genetics” cluster (Right: The Source) to the “Medicine, Medical, Clinical” cluster (Left: The Destination). This trajectory confirms that intestinal organoids are acting as a translational vehicle, effectively converting fundamental discoveries in stem cell genetics into actionable clinical tools for IBD and regenerative medicine. Table 4A Top10 journals related to the research of intestinal organoids. B Top ten co-cited journals related to the research of intestinal organoidsARankJournalCountriesCountIF (2024)JCR (2024)H-indexTotal citations1.GastroenterologyUSA13725.1Q14694182.SCI REP-UKUK793.9Q12328343.INT J MOL SCISwitzerland754.9Q12113364.Cell Mol Gastroenterol HepatolUSA677.4Q13025275.Nat. Commun.UK5715.7Q13432856.JOVE-J VIS EXPUSA561Q3157287.AM J PHYSIOL-GASTR LUSA503.3Q22216688.Front. Immunol.Switzerland405.9Q1157399.Cell Rep.USA396.9Q124239310.PNASUSA399.1Q1262630BRankCo-cited JournalCountriesCitationIF (2024)JCR (2024)1.NatureUK10,53448.5Q12.GastroenterologyUSA543825.1Q13.CellUSA510442.5Q14.ScienceUSA429245.8Q15.PNASUSA43269.1Q16.Cell Stem CellUSA352620.4Q17.Nat. Commun.UK290115.7Q18.SCI REP-UKUK27263.9Q19.Plos oneUSA29572.6Q210.Nat. Med.USA255050Q1 Table 4A Top10 journals related to the research of intestinal organoids. B Top ten co-cited journals related to the research of intestinal organoidsARankJournalCountriesCountIF (2024)JCR (2024)H-indexTotal citations1.GastroenterologyUSA13725.1Q14694182.SCI REP-UKUK793.9Q12328343.INT J MOL SCISwitzerland754.9Q12113364.Cell Mol Gastroenterol HepatolUSA677.4Q13025275.Nat. Commun.UK5715.7Q13432856.JOVE-J VIS EXPUSA561Q3157287.AM J PHYSIOL-GASTR LUSA503.3Q22216688.Front. Immunol.Switzerland405.9Q1157399.Cell Rep.USA396.9Q124239310.PNASUSA399.1Q1262630BRankCo-cited JournalCountriesCitationIF (2024)JCR (2024)1.NatureUK10,53448.5Q12.GastroenterologyUSA543825.1Q13.CellUSA510442.5Q14.ScienceUSA429245.8Q15.PNASUSA43269.1Q16.Cell Stem CellUSA352620.4Q17.Nat. Commun.UK290115.7Q18.SCI REP-UKUK27263.9Q19.Plos oneUSA29572.6Q210.Nat. Med.USA255050Q1 A Top10 journals related to the research of intestinal organoids. B Top ten co-cited journals related to the research of intestinal organoids Fig. 5Journal and citation dynamics. A Annual publication heatmap of the top 25 journals. B Journal network exhibiting clustered collaborative relationships. C Dual-map overlay of journals. The colored curves represent citation paths, originating from the “Molecular, Biology, Genetics” base (Right) and targeting the “Medicine, Medical, Clinical” frontier (Left). D Bradford’s Law distribution showing the core journals (Zone 1) of the field. E Co-citation network delineating thematic associations among influential publications Journal and citation dynamics. A Annual publication heatmap of the top 25 journals. B Journal network exhibiting clustered collaborative relationships. C Dual-map overlay of journals. The colored curves represent citation paths, originating from the “Molecular, Biology, Genetics” base (Right) and targeting the “Medicine, Medical, Clinical” frontier (Left). D Bradford’s Law distribution showing the core journals (Zone 1) of the field. E Co-citation network delineating thematic associations among influential publications The intellectual base: landmark studies and thematic evolution Top-cited publications represent the bedrock of scientific knowledge. As detailed in Table 5, the ten most cited articles delineate the evolutionary trajectory of intestinal organoid research, evolving from technique establishment to mechanistic deep-dives, and finally to critical clinical applications. The field is anchored by the seminal work of Sato T. and Clevers H., who occupy multiple positions in the top list (Rank 1, 2, 3, and 10). The 2009 Nature paper (Rank 1) is the undisputed “Big Bang” of the field, amassing over 6,500 citations [5]. Its historical significance lies in overturning the dogma that epithelial cells require a mesenchymal niche to survive directly. By identifying Lgr5 + stem cells and defining the requisite growth factors (R-spondin1, Noggin, EGF), this study established the first long-term “Self-Organizing” culture system. By 2011, Sato extended this to human tissues and cancer models (Rank 2), proving that the technology was not just a murine curiosity but a robust tool for human disease modeling [26]. Rank 4 (Spence JR et al., 2011) marks a critical divergence in methodology. While Sato focused on adult stem cells (ASCs) from biopsies, Spence developed protocols to generate intestinal organoids from human Pluripotent Stem Cells (iPSCs/ESCs) [19]. This duality (ASC vs. PSC) remains a central theme in the field. ASC-intestinal organoids are preferred for personalized medicine (reflecting the donor’s precise age and mutations), while PSC-intestinal organoids are indispensable for studying embryonic development and congenital defects. The list highlights the first successful demonstration of intestinal organoid-based precision medicine. Schwank G et al. (2013, Rank 8) combined intestinal organoid technology with CRISPR/Cas9 to correct the CFTR mutation in Cystic Fibrosis (CF) intestinal organoids [22]. This was a pivotal moment. The study didn’t just grow cells; it functionally restored chloride channel activity (swelling assay), proving that intestinal organoids could serve as “avatars” for predicting drug response and validating gene therapies. This laid the groundwork for the high ranking of subsequent CF reviews (Fatehullah A, 2016, Rank 7). The remaining papers illustrate the unique capability of intestinal organoids to host pathogens that were previously unculturable. Norovirus (Rank 9): Ettayebi et al. (2016) solved a 40-year-old challenge by successfully culturing human Norovirus in intestinal organoids, a feat impossible in standard 2D cell lines [23]. COVID-19 (Rank 5): Notably, Lamers MM et al. (2020) achieved Rank 5 in just four years, with an extraordinary average of 281.4 citations per year. This study identified the intestine as a target for SARS-CoV-2 (via ACE2 receptors). The rapid accumulation of citations highlights the field’s agility and maturity—intestinal organoid technology was ready to be immediately deployed to address a global health crisis [27]. Table 5The top ten intestinal organoids-related original articles with the most citationsTitleFirst authorJournalYearTotal citationsAverage per yearMain conclusionSingle Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheSatoNature20096524407.75The intestinal epithelium rapidly renews itself in adult mammals. We found that small intestinal crypts contain about six active Lgr5 + stem cells. We developed a long-term culture method where a single crypt can multiply and form villus-like structures containing all mature cell types. Even a single Lgr5 + stem cell can grow into these “crypt-villus” organoids, which maintain the original stem cell hierarchy. This shows that intestinal crypt-villus units are self-organizing and can form from just one stem cell, without support from other cell types.Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett’s EpitheliumSatoGastroenterology20113404243.14This study successfully established an optimized long-term culture system for intestinal organoids, which supports the expansion of both normal and pathological tissues—including intestinal adenomas, colorectal cancers, and metaplastic epithelia from Barrett’s esophagus—from mice and humans. This system provides a powerful in vitro platform for investigating gastrointestinal diseases and advancing regenerative medicine, while also demonstrating that adult stem cells possess extended replicative potential beyond conventional limits in ex vivo culture.Paneth cells constitute the niche for Lgr5 stem cells in intestinal cryptsSatoNature20112406171.86Homeostasis in small intestinal crypts is maintained through neutral competition among Lgr5 + stem cells. We demonstrate that Paneth cells, which are intermingled with Lgr5 + stem cells, serve as an essential niche component by providing key signals—including EGF, TGF-α, Wnt3, and Dll4. Co-culture with Paneth cells enhances organoid formation from single Lgr5 + stem cells, and their genetic ablation in vivo leads to stem cell loss. In the colon, CD24 + cells may fulfill a similar supportive role. These findings establish that Lgr5 + stem cells depend on signals from their differentiated Paneth cell progeny for maintenance.Directed differentiation of human pluripotent stem cells into intestinal tissue in vitroSpenceNature20111832130.86This study established a stepwise protocol that directs the differentiation of human pluripotent stem cells into three-dimensional intestinal organoids by recapitulating key embryonic developmental stages. The resulting organoids, which contain all major intestinal cell types and exhibit characteristic crypt-villus architecture, provide a robust platform for investigating human intestinal development. Using this model, we identified essential roles for specific signaling pathways and transcription factors, offering new insights into disease mechanisms and regenerative potential.SARS-CoV-2 productively infects human gut enterocytesLamersScience20201407281.4Although SARS-CoV-2 is primarily considered a respiratory pathogen, clinical evidence indicates that the intestine may serve as an alternative target organ. This is supported by high expression of the viral entry receptor ACE2 on differentiated enterocytes. Using human small intestinal organoids, we demonstrated that enterocytes are highly susceptible to SARS-CoV-2 infection, produce infectious viral progeny, and mount a robust antiviral response. These findings establish intestinal epithelium as a permissive site for SARS-CoV-2 replication and highlight human intestinal organoids as a physiologically relevant model for studying coronavirus infection.A single-cell survey of the small intestinal epitheliumHaberNature20171427178.38We performed single-cell RNA sequencing of 53,193 intestinal epithelial cells from mouse small intestine and organoids, revealing previously undefined cell subtypes and their transcriptional signatures. Our analysis uncovered unexpected heterogeneity in enteroendocrine cells and identified two distinct tuft cell subsets—one expressing the epithelial cytokine TSLP and the pan-immune marker CD45, a marker not previously associated with non-hematopoietic cells. We further characterized how epithelial cell states and population dynamics shift in response to infection: Salmonella infection increased Paneth and enterocyte abundance and broadly activated antimicrobial programs, whereas Heligmosomoides polygyrus infection expanded goblet and tuft cell populations. This study provides a detailed cellular taxonomy of the intestinal epithelium, links sensory molecules to specific cell types, and delineates fundamental principles of gut homeostasis and pathogen response.Organoids as an in vitro model of human development and diseaseFatehullahNature Cell Biology20161349149.89Intestinal stem cells from both mice and humans can be expanded long-term as genetically stable epithelial organoids. While increased cAMP triggers rapid organoid swelling via CFTR channel opening, this response is absent in organoids derived from cystic fibrosis patients. We employed CRISPR/Cas9-mediated homologous recombination to correct the CFTR locus in cultured intestinal stem cells from CF patients. The corrected allele showed full expression and function in clonally expanded organoids. This study demonstrates proof of concept for gene correction via homologous recombination in patient-derived adult stem cells carrying a monogenic hereditary defect.Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis PatientsSchwankCell Stem Cell20131345112.08We demonstrate that CRISPR/Cas9-mediated homologous recombination can correct the CFTR locus in intestinal stem cells from cystic fibrosis patients. The genetically repaired allele restores CFTR channel function in long-term expanded organoids, as shown by recovered cAMP-induced swelling responses. This establishes proof of concept for precise gene correction in patient-derived adult stem cells with monogenic defects.Replication of human noroviruses in stem cell-derived human enteroidsEttayebiScience20161201133.44A major obstacle in human norovirus (HuNoV) research has been the absence of a reliable cultivation system. We successfully established replication of multiple HuNoV strains in stem cell-derived human intestinal enteroid monolayers. Strain-dependent replication required bile, a key intestinal factor. Viral replication was restricted by the absence of appropriate histoblood group antigens and was abolished by inactivation or serum neutralization. This physiologically relevant culture system enables previously inaccessible human host-pathogen studies and provides a platform for developing interventions against HuNoV.Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and ApplicationsSatoScience2013108990.75Lgr5, a marker for stem cells in multiple adult tissues, enables long-term expansion of self-organizing epithelial organoids that retain tissue-specific identity when cultured with R-spondin. This review examines the mechanisms underlying this robust in vitro morphogenesis and discusses its broad applications in stem cell biology, disease modeling (including colorectal cancer and cystic fibrosis), and regenerative medicine. Table 5The top ten intestinal organoids-related original articles with the most citationsTitleFirst authorJournalYearTotal citationsAverage per yearMain conclusionSingle Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheSatoNature20096524407.75The intestinal epithelium rapidly renews itself in adult mammals. We found that small intestinal crypts contain about six active Lgr5 + stem cells. We developed a long-term culture method where a single crypt can multiply and form villus-like structures containing all mature cell types. Even a single Lgr5 + stem cell can grow into these “crypt-villus” organoids, which maintain the original stem cell hierarchy. This shows that intestinal crypt-villus units are self-organizing and can form from just one stem cell, without support from other cell types.Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett’s EpitheliumSatoGastroenterology20113404243.14This study successfully established an optimized long-term culture system for intestinal organoids, which supports the expansion of both normal and pathological tissues—including intestinal adenomas, colorectal cancers, and metaplastic epithelia from Barrett’s esophagus—from mice and humans. This system provides a powerful in vitro platform for investigating gastrointestinal diseases and advancing regenerative medicine, while also demonstrating that adult stem cells possess extended replicative potential beyond conventional limits in ex vivo culture.Paneth cells constitute the niche for Lgr5 stem cells in intestinal cryptsSatoNature20112406171.86Homeostasis in small intestinal crypts is maintained through neutral competition among Lgr5 + stem cells. We demonstrate that Paneth cells, which are intermingled with Lgr5 + stem cells, serve as an essential niche component by providing key signals—including EGF, TGF-α, Wnt3, and Dll4. Co-culture with Paneth cells enhances organoid formation from single Lgr5 + stem cells, and their genetic ablation in vivo leads to stem cell loss. In the colon, CD24 + cells may fulfill a similar supportive role. These findings establish that Lgr5 + stem cells depend on signals from their differentiated Paneth cell progeny for maintenance.Directed differentiation of human pluripotent stem cells into intestinal tissue in vitroSpenceNature20111832130.86This study established a stepwise protocol that directs the differentiation of human pluripotent stem cells into three-dimensional intestinal organoids by recapitulating key embryonic developmental stages. The resulting organoids, which contain all major intestinal cell types and exhibit characteristic crypt-villus architecture, provide a robust platform for investigating human intestinal development. Using this model, we identified essential roles for specific signaling pathways and transcription factors, offering new insights into disease mechanisms and regenerative potential.SARS-CoV-2 productively infects human gut enterocytesLamersScience20201407281.4Although SARS-CoV-2 is primarily considered a respiratory pathogen, clinical evidence indicates that the intestine may serve as an alternative target organ. This is supported by high expression of the viral entry receptor ACE2 on differentiated enterocytes. Using human small intestinal organoids, we demonstrated that enterocytes are highly susceptible to SARS-CoV-2 infection, produce infectious viral progeny, and mount a robust antiviral response. These findings establish intestinal epithelium as a permissive site for SARS-CoV-2 replication and highlight human intestinal organoids as a physiologically relevant model for studying coronavirus infection.A single-cell survey of the small intestinal epitheliumHaberNature20171427178.38We performed single-cell RNA sequencing of 53,193 intestinal epithelial cells from mouse small intestine and organoids, revealing previously undefined cell subtypes and their transcriptional signatures. Our analysis uncovered unexpected heterogeneity in enteroendocrine cells and identified two distinct tuft cell subsets—one expressing the epithelial cytokine TSLP and the pan-immune marker CD45, a marker not previously associated with non-hematopoietic cells. We further characterized how epithelial cell states and population dynamics shift in response to infection: Salmonella infection increased Paneth and enterocyte abundance and broadly activated antimicrobial programs, whereas Heligmosomoides polygyrus infection expanded goblet and tuft cell populations. This study provides a detailed cellular taxonomy of the intestinal epithelium, links sensory molecules to specific cell types, and delineates fundamental principles of gut homeostasis and pathogen response.Organoids as an in vitro model of human development and diseaseFatehullahNature Cell Biology20161349149.89Intestinal stem cells from both mice and humans can be expanded long-term as genetically stable epithelial organoids. While increased cAMP triggers rapid organoid swelling via CFTR channel opening, this response is absent in organoids derived from cystic fibrosis patients. We employed CRISPR/Cas9-mediated homologous recombination to correct the CFTR locus in cultured intestinal stem cells from CF patients. The corrected allele showed full expression and function in clonally expanded organoids. This study demonstrates proof of concept for gene correction via homologous recombination in patient-derived adult stem cells carrying a monogenic hereditary defect.Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis PatientsSchwankCell Stem Cell20131345112.08We demonstrate that CRISPR/Cas9-mediated homologous recombination can correct the CFTR locus in intestinal stem cells from cystic fibrosis patients. The genetically repaired allele restores CFTR channel function in long-term expanded organoids, as shown by recovered cAMP-induced swelling responses. This establishes proof of concept for precise gene correction in patient-derived adult stem cells with monogenic defects.Replication of human noroviruses in stem cell-derived human enteroidsEttayebiScience20161201133.44A major obstacle in human norovirus (HuNoV) research has been the absence of a reliable cultivation system. We successfully established replication of multiple HuNoV strains in stem cell-derived human intestinal enteroid monolayers. Strain-dependent replication required bile, a key intestinal factor. Viral replication was restricted by the absence of appropriate histoblood group antigens and was abolished by inactivation or serum neutralization. This physiologically relevant culture system enables previously inaccessible human host-pathogen studies and provides a platform for developing interventions against HuNoV.Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and ApplicationsSatoScience2013108990.75Lgr5, a marker for stem cells in multiple adult tissues, enables long-term expansion of self-organizing epithelial organoids that retain tissue-specific identity when cultured with R-spondin. This review examines the mechanisms underlying this robust in vitro morphogenesis and discusses its broad applications in stem cell biology, disease modeling (including colorectal cancer and cystic fibrosis), and regenerative medicine. The top ten intestinal organoids-related original articles with the most citations Intellectual base and temporal evolution of research hotspots The analysis of top co-cited references (Table 6) reveals the “intellectual base”—the collection of works that subsequent researchers fundamentally rely upon. The list is characterized by a “Founder Dominance.” Sato T. and Clevers H. author 5 of the top 7 papers. The “Marker” and the “Method”: The logic of the field is clearly visible: first came the identification of the stem cell marker Lgr5 [28] (Barker N, Nature, 2007, Rank 4), followed immediately by the establishment of the culture system [5] (Sato T, Nature, 2009, Rank 1). The “Gold Standards”: Notably, the top 4 papers are all from Nature or Gastroenterology. These articles effectively serve as the “instruction manuals” of the field. The high citation counts of Sato [26] (2011) and Spence [19] (2011) indicate that despite a decade of progress, the community relies heavily on the original protocols for both ASC-derived and PSC-derived intestinal organoids. Citation burst detection identifies references that captured immediate widespread attention during specific periods. As shown in the “Top 25 References with Strongest Citation Bursts” (Fig. 6), the field has undergone three distinct evolutionary phases: Phase I: Establishment & Expansion (2010–2016) The earliest bursts (top red bars) map the foundational era. Sato [5, 16] and Yui [29]. Papers in this phase focused on proving that “it works” (creating mini-guts from single cells) and “it repairs” (transplantation into colitis models). The defining characteristic was the validation of the Lgr5 + culture system. Phase II: Biobanking & Translational Modeling (2015–2020). The middle cluster of bursts reveals a shift towards large-scale clinical application. van de Wetering (2015) [30] and Drost [31] showing prolonged bursts (2016–2020). These papers introduced the concept of “Living Biobanks.” Researchers moved from observing healthy gut to collecting tumor intestinal organoids from colorectal cancer patients, linking genotype to drug sensitivity. This era marked the transition of intestinal organoids from a developmental biology tool to a precision oncology platform. Phase III: The “Next-Gen” Frontier (2020–Present). The most critical insights lie in the references with bursts extending to 2023–2025 (bottom red bars), as they predict current and future trends. The burst of Kasendra M (2018) is significant. This Scientific Reports paper describes “Intestine-on-a-Chip.” This signals a dissatisfaction with static Matrigel domes. The field is moving towards microfluidic devices that incorporate flow, peristalsis, and microbiome interactions to mimic the physical gut environment more accurately [32]. Nikolaev M (2020, Nature) shows a strong ongoing burst. This suggests a rising interest in how tissue shape is determined by physical forces (mechanosensing), moving beyond pure genetics [33]. New high-impact reviews or methods (e.g., Beumer J, 2021) highlight the refinement of culture conditions to sustain rare cell types or improve reproducibility [34]. The burst analysis narrates a clear scientific maturation: from Biological Discovery [5] (Lgr5, 2009) to Clinical Application (Biobanks, 2015) and now towards Biophysical Engineering (Organs-on-Chip, 2020–2025). Table 6Top ten co-cited references concerning the research of intestinal organoidsTitleFirst authorJournalIFJCRYearCitationsSingle Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheSatoNature48.5Q120096524Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett’s EpitheliumSatoGastroenterology25.1Q120113404Directed differentiation of human pluripotent stem cells into intestinal tissue in vitroSpenceNature48.5Q120111832Identification of stem cells in small intestine and colon by marker gene Lgr5BarkerNature48.5Q120074534Paneth cells constitute the niche for Lgr5 stem cells in intestinal cryptsSatoNature48.5Q120112406Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patientsvan de WeteringCell42.5Q120152028Modeling Development and Disease with OrganoidsCleversCell42.5Q120162729A functional CFTR assay using primary cystic fibrosis intestinal organoidsDekkersNature Medicine50Q12013967Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5 + stem cellYuiNature Medicine50Q12012773Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell nicheOotaniNature Medicine50Q12009857 Table 6Top ten co-cited references concerning the research of intestinal organoidsTitleFirst authorJournalIFJCRYearCitationsSingle Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheSatoNature48.5Q120096524Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett’s EpitheliumSatoGastroenterology25.1Q120113404Directed differentiation of human pluripotent stem cells into intestinal tissue in vitroSpenceNature48.5Q120111832Identification of stem cells in small intestine and colon by marker gene Lgr5BarkerNature48.5Q120074534Paneth cells constitute the niche for Lgr5 stem cells in intestinal cryptsSatoNature48.5Q120112406Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patientsvan de WeteringCell42.5Q120152028Modeling Development and Disease with OrganoidsCleversCell42.5Q120162729A functional CFTR assay using primary cystic fibrosis intestinal organoidsDekkersNature Medicine50Q12013967Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5 + stem cellYuiNature Medicine50Q12012773Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell nicheOotaniNature Medicine50Q12009857 Top ten co-cited references concerning the research of intestinal organoids Fig. 6CiteSpace visualization map of top 25 references with the strongest citation bursts from 2000 to 2025 CiteSpace visualization map of top 25 references with the strongest citation bursts from 2000 to 2025 Research hotspots and thematic architecture Keywords delineate the conceptual boundaries of a scientific domain. As detailed in Table 7 and visualizing the frequency distribution (Fig. 7A), the field relies on a lexicon dominated by “stem-cells” (Frequency: 666) and “in-vitro” (Frequency: 657). However, traversing down the list reveals the strategic functionalization of these cells: “differentiation” (Rank 6), “inflammation” (Rank 10), and “cancer” (Rank 11). The Thematic Map (Fig. 7C) and Correlation Matrix (Fig. 7B) further cluster these terms into three distinct conceptual pillars: The Technical Pillar (Blue Cluster): Centered on terms like “expansion,” “in-vitro,” and “human colon.” This cluster represents the ongoing refinement of culture conditions to ensure stability and reproducibility. The Mechanistic Pillar (Yellow Cluster): Anchored by “homeostasis,” “differentiation,” and “Wnt signaling.” This reflects the use of intestinal organoids to dissect the molecular pathways governing gut renewal and stem cell maintenance. The Clinical Pillar (Red Cluster): Defined by “disease,” “inflammation,” and “models.” This signifies the translational terminus of the research-using intestinal organoids to mimic pathologies like IBD. The Trend Topics analysis (Fig. 7D) is the most critical indicator of future directions. By mapping term frequency over time, we observe a distinct three-stage metamorphosis of the field: Stage 1: The “Establishment” Era (2011–2016). The earliest terms (bottom/left of Fig. 7D) focus on developmental fundamentals: “embryonic stem-cells,” “endoderm,” and “Wnt receptors.” During this period, the primary goal was determining how to grow these structures and confirming their biological identity. Stage 2: The “Modeling” Era (2017–2020). A shift occurred towards specific pathologies. Terms like “tumorigenesis,” “colorectal-cancer,” and “bacterial infection” surged. This era corresponds to the heavy usage of intestinal organoids as disease models (as seen in the Burst Analysis of Biobanks). Stage 3: The “Precision & Tech” Era (2021–2025). The most recent terms (at the top of Fig. 7D) reveal the current frontier. “Atlas” & “Prediction”: These terms point towards the integration of Single-Cell RNA Sequencing (scRNA-seq) and Computational Biology. Researchers are no longer just looking at intestinal organoids; they are building “Cell Atlases” to map heterogeneity at high resolution and using these datasets for drug response prediction. “Nanoparticles”: This indicates a budding intersection with Material Science. Intestinal organoids are becoming testbeds for novel drug delivery systems, particularly for crossing the intestinal barrier. “Metabolism”: This marks a shift from structural biology to functional metabolic profiling, likely linked to gut microbiota studies. The trajectory is clear: The field has moved from making the model, to using the model for disease, and is now enhancing the model with high-throughput omics and nanotechnology. Table 7The top 20 keywords with the highest frequency related to the research of intestinal organoidsRankKeywordsFrequencyTLSRankKeywordsFrequencyTLS1Stem-cells666501611Cancer20615962In-vitro657539312Organoid20417153Organoids634510713Disease19014574Expression547419214Activation18314455Intestinal organoids367285815Growth15611446Differentiation350284516Identification15311377Colon264209117Expansion15011878Model233185418Homeostasis14811819Cells233155919Human colon144116610Inflammation212168220Mouse1421128 Table 7The top 20 keywords with the highest frequency related to the research of intestinal organoidsRankKeywordsFrequencyTLSRankKeywordsFrequencyTLS1Stem-cells666501611Cancer20615962In-vitro657539312Organoid20417153Organoids634510713Disease19014574Expression547419214Activation18314455Intestinal organoids367285815Growth15611446Differentiation350284516Identification15311377Colon264209117Expansion15011878Model233185418Homeostasis14811819Cells233155919Human colon144116610Inflammation212168220Mouse1421128 The top 20 keywords with the highest frequency related to the research of intestinal organoids Fig. 7Keyword co-occurrence analysis and thematic evolution of the intestinal organoid field. A Word Cloud visualization of the top 50 most frequent keywords. B Correlation Matrix Heatmap displaying the co-occurrence relationships between high-frequency keywords. C Conceptual Structure Map generated via Multiple Correspondence Analysis (MCA). D Trend Topics analysis illustrating the temporal evolution of research hotspots from 2011 to 2025 Keyword co-occurrence analysis and thematic evolution of the intestinal organoid field. A Word Cloud visualization of the top 50 most frequent keywords. B Correlation Matrix Heatmap displaying the co-occurrence relationships between high-frequency keywords. C Conceptual Structure Map generated via Multiple Correspondence Analysis (MCA). D Trend Topics analysis illustrating the temporal evolution of research hotspots from 2011 to 2025 The advantages and applications of intestinal organoids The co-occurrence network and burst detection analysis presented reveal a pivotal shift in the field’s trajectory since 2018. While early research focused heavily on Stem cell differentiation and Culture protocols, recent burst terms such as Drug screening, Host-pathogen interaction, and SARS-CoV-2 indicate a transition towards functional clinical applications. Based on these high-centrality clusters, we categorize the current application landscape into the following critical domains. The advantages of intestinal organoids Recent advancements in intestinal organoid technology have revitalized biomedical research. Although still in its early developmental stages, this technology has shown distinct advantages in simulating the complex physiological systems of the human body. Compared to traditional animal models and two-dimensional cell culture systems, intestinal organoid technology overcomes the spatial limitations of in vitro experimental systems, creating miniature models that closely resemble the structure and function of real organs while accurately reproducing the three-dimensional dynamic behavior of stem cells. The significant progress made in this technology not only paves the way for research on bionic organs but also enables a deeper analysis of multi-cell interaction networks. This ranges from systematically decoding the mechanisms underlying intestinal diseases to precisely screening new drug targets and iteratively enhancing regenerative medicine technologies. Organoid models are fundamentally reshaping the entire research paradigm. As a highly controllable in vitro research platform, intestinal organoids establish a crucial link between basic research and clinical application. Their standardized operating procedures and advantages in repeatability have markedly accelerated the translation of scientific research findings into clinical practice, showcasing substantial potential for advancing precision medicine [35]. The current advancement in intestinal organoid research relies heavily on the concurrent breakthroughs of several cutting-edge technologies. Single-cell sequencing, 3D bioprinting, and novel small molecule tracer imaging collectively establish a comprehensive technical framework for intestinal organoid research. Single-cell sequencing not only characterizes the molecular features of intestinal organoid cell populations but also traces the dynamic evolution of specific cell subpopulations throughout differentiation. This detailed single-cell analysis serves as a crucial starting point for elucidating the principles of cell fate determination in intestinal regenerative medicine [36]. Integration of 3D printing enables the precise fabrication of various intestinal organoid structures tailored to clinical requirements [37]. Small molecule tracer imaging technology allows real-time monitoring of internal dynamic changes in intestinal organoids, offering direct observational evidence for tracking drug intervention effects and disease progression. The combined utilization of these technologies has propelled intestinal organoid research to a more profound and extensive level, establishing a robust groundwork for precision medicine and regenerative medicine development. Applications of intestinal organoids From damage to regeneration: radiation and chemotherapy injury Our keyword trend analysis revealed persistent clusters revolving around DNA damage, apoptosis, stem cell niche, and regeneration, reflecting the urgent clinical need to mitigate the off-target gastrointestinal toxicity of radiotherapy and chemotherapy. Unlike traditional 2D cell lines, intestinal organoids preserve the crypt–villus architecture and the LGR5 + intestinal stem cell (ISC) niche, making them an increasingly important platform for studying radiation-induced intestinal injury (RIII) and for evaluating intervention strategies. Based on the bibliometric landscape and recent high-impact literature, current intestinal organoid-based intervention studies encompass a diverse range of mechanistic approaches that can be conceptually organized into several complementary categories. One foundational strategy involves intestinal stem cell- and intestinal organoid-based transplantation for epithelial regeneration. Pioneering work by Yui et al. demonstrated that ex vivo–expanded intestinal organoids can engraft into damaged colonic epithelium and reconstitute functional crypts, providing proof-of-concept for intestinal organoid-based regenerative therapy after intestinal injury [38]. Subsequent studies extended this approach to radiation-injured intestine, showing that transplantation of intestinal stem cells or intestinal organoid-derived epithelial sheets can accelerate epithelial recovery and improve survival in irradiated animals [39]. These findings establish the feasibility of cell-based therapies for radiation enteritis and highlight the regenerative potential of ex vivo–expanded intestinal epithelium. A second major area of investigation focuses on modulation of regenerative signaling pathways that govern ISC survival and crypt regeneration. Multiple intestinal organoid studies have dissected how Wnt/β-catenin, R-spondin/LGR5, Notch, BMP, EGF, and Hippo/YAP–TAZ signaling regulate epithelial repair after radiation. For example, Bhanja et al. showed that BCN057 mitigates radiation-induced damage to LGR5 + stem cells via the Wnt/β-catenin pathway [40]. Activation of YAP/TAZ has been reported to drive a transient regenerative state in irradiated intestinal epithelium, supporting crypt repopulation [41]. R-spondin1 and Wnt agonists have similarly been shown to enhance intestinal organoid recovery after irradiation [42]. These studies underscore the central role of niche signaling in epithelial resilience and identify tractable molecular targets for radioprotection. Closely related to pathway modulation is the targeting of apoptosis and the DNA damage response. Radiation-induced loss of LGR5 + ISCs is largely driven by p53–PUMA-mediated apoptosis. Using intestinal organoid and in vivo models, Leibowitz et al. demonstrated that PUMA inhibition blocks chemotherapy- and radiation-triggered ISC apoptosis without compromising tumor control [43]. Nag et al. identified Auranofin as a radioprotector that promotes p53/p21-mediated cell-cycle arrest and DNA repair in intestinal organoids [44]. These studies establish the DNA damage response axis as a tractable target in intestinal organoid-based radioprotection and suggest that selective inhibition of pro-apoptotic pathways may preserve epithelial integrity during cancer therapy. Beyond direct modulation of stem cell survival, anti-oxidative, anti-inflammatory, and barrier-protective strategies have emerged as important complementary approaches. Ionizing radiation triggers reactive oxygen species (ROS) accumulation, NF-κB activation, and pro-inflammatory cytokine release, which collectively impair epithelial barrier function. Intestinal organoid studies have evaluated antioxidants, NRF2 activators, and anti-inflammatory agents for their ability to preserve epithelial integrity, reduce apoptosis, and restore tight junction proteins after irradiation [45, 46]. Such studies underscore the value of intestinal organoids as a quantitative readout for barrier function and oxidative stress response, and they highlight the potential of multi-targeted interventions that address both stem cell loss and barrier dysfunction. An emerging frontier in radiation injury research involves microbiota- and metabolite-based interventions. A growing body of evidence indicates that gut microbiota and microbial metabolites modulate intestinal radiosensitivity and regenerative capacity. Short-chain fatty acids (e.g., butyrate), tryptophan-derived indole metabolites, and bile acid derivatives have been shown to enhance ISC survival and epithelial repair in intestinal organoid co-culture systems [47]. These findings highlight the potential of intestinal organoid–microbiota co-culture platforms to enable mechanistic dissection of host–microbe interactions in radiation injury and to identify microbiome-derived therapeutics for radioprotection. Finally, intestinal organoids are increasingly used as scalable ex vivo platforms for drug repurposing and natural-compound–based radioprotector screening. Repurposed clinical drugs and natural compounds (e.g., flavonoids, polyphenols) have been evaluated for their radioprotective and radiation-mitigating properties using intestinal organoid-based assays [48, 49]. The advantages of patient-derived or species-matched intestinal organoids—such as preserved ISC hierarchy, tractable readouts, and compatibility with high-content imaging—make them well suited for translational radioprotection pipelines and for identifying clinically actionable interventions. These studies illustrate the breadth and mechanistic diversity of intestinal organoid-based intervention strategies for radiation- and chemotherapy-induced intestinal injury. However, the bibliometric pattern also reveals a clear “cell-only” limitation: most current studies focus on epithelial responses in isolation, while radiation enteritis in vivo involves coordinated contributions from immune cells, stromal cells, vasculature, and the microbiota. Future high-impact work should integrate immune components, stromal niches, and microbial communities into intestinal organoid platforms—via co-culture, intestinal organoid-on-a-chip, and microfluidic systems—to fully recapitulate the cytokine storm and ecological dysregulation associated with radiation enteritis. Equally important, the field will benefit from standardized phenotypic assessment to enable cross-laboratory comparison of intervention efficacy and to accelerate the translation of intestinal organoid-based discoveries into clinical radioprotection strategies. Host-pathogen interactions: intestinal infection Intestinal infections are diseases caused by various pathogens, including bacteria, viruses, and parasites. These infections pose a significant challenge to global public health and result in numerous fatalities each year. Although many researchers have conducted extensive studies on these diseases, existing experimental models currently exhibit substantial deficiencies in simulating the pathogenesis of intestinal infections. Specifically, these models do not adequately replicate the complex pathophysiological changes that occur during intestinal tract infections, particularly the damage and repair mechanisms of intestinal epithelial cells post-infection. This limitation significantly hinders researchers’ ability to gain a deeper understanding of these mechanisms. Recently, the advent of intestinal organoid technology has introduced a novel approach for studying intestinal infections. This model not only preserves the interactions among intestinal epithelial cells, interstitial cells, and intestinal microbiota but also realistically reproduces the interactions between pathogens and host cells, as well as the resulting pathological changes during intestinal infection.In the study of bacterial infections, intestinal organoids serve as effective models for simulating the in vivo infection processes of various human pathogenic intestinal bacteria, including Salmonella and Typhimurium. These intestinal organoids provide researchers with a valuable platform for exploring the mechanisms underlying intestinal epithelial cell damage and subsequent repair following infection [29]. In the context of viral infections, intestinal organoids have successfully replicated key cytotoxic characteristics associated with viral infection [50]. For example, when intestinal organoids are infected with viruses such as avian influenza strains, these pathogens specifically target and destroy Paneth cells within the intestinal organoids. This destruction adversely affects the proliferation and differentiation of intestinal stem cells, thereby interfering with the regeneration and repair of the intestinal epithelium and exacerbating the pathological damage caused by viral infection [51]. Furthermore, in the realm of parasitic infection research, researchers have constructed intestinal organoid infection models that target Cryptosporidium and Toxoplasma gondii. These models not only closely mimic the natural infection environment of parasites in the human intestinal tract but also accurately reproduce the biological behaviors observed during the parasitic infection process and the pathogenesis that ensues [52]. Genetic disease & individualized therapy: the cystic fibrosis paradigm Bibliometric clusters associated with CRISPR/Cas9 and CFTR highlight the role of intestinal organoids in monogenic diseases. Cystic Fibrosis (CF) represents the most mature clinical implementation of intestinal organoid technology, often cited as the field’s “Translation Success Story.” Because traditional drug development suffers from high failure rates due to patient heterogeneity, the “Rectal Organoid Swelling Assay” described by Berkers et al. [53] has revolutionized the standard of care. This bioassay allows for the ex vivo prediction of drug efficacy (e.g., VX-770 response) with high correlation to clinical outcomes. This success has cemented intestinal organoids as a predictive biomarker tool, validating the keyword trend towards Precision Medicine. Inflammatory bowel disease (IBD): modeling chronic inflammation The keyword Inflammation often co-occurs with Cytokines, Fibrosis, and Barrier function. This suggests that researchers are moving away from chemical-induced mouse models (e.g., DSS colitis) toward human-relevant in vitro systems. Intestinal organoids offer a superior platform for dissecting the specific roles of cytokines (e.g., TNF-α, TGF-β1) in intestinal fibrosis, as demonstrated by the Hahn research group [54]. Unlike 2D lines, intestinal organoids can simulate the epithelial-mesenchymal transition (EMT) essential for fibrosis. However, current citation patterns suggest a gap in “Multi-organ” IBD models, pointing towards a future need for Gut-Immune-Microbiome co-culture systems. Precision oncology: the rise of biobanks Research on CRC accounts for the largest volume of publications in our dataset. The bibliometric evolution clearly tracks a move from Carcinogenesis mechanism (basic science) to Patient-Derived intestinal Organoids (clinical tools). Patient-Derived intestinal Organoid biobanks have effectively addressed the issue of tumor heterogeneity that plagues cell lines [55–57]. Studies utilizing CRISPR-Cas9 within these intestinal organoids, such as those by Takeda et al. [58], have identified novel tumor suppressors like Acvr1b, which were overlooked in simpler models. A critical challenge identified in the “Time-lag” analysis of citations is the speed of culture establishment; future impact will depend on rapid diagnostic pipelines that can guide treatment within a clinical timeframe. Thus, bibliometric evidence suggests a pressing need for automation over manual culture to bridge this temporal gap. Next-generation pharmacokinetics: replacing caco-2 While Caco-2 remains a standard keyword, its relative centrality is declining in favor of intestinal organoids and organ-on-chip in drug transport studies. This reflects a recognition of the limitations of Caco-2 monolayers, which lack the diversity of transporter proteins found in native tissue. Recent literature demonstrates organoids’ superiority in evaluating key transporters like P-glycoprotein (P-gp) and BCRP [59–61]. Furthermore, the emergence of the keyword Nanoparticles in the 2022–2024 cluster indicates that intestinal organoids are now the preferred model for testing novel drug delivery systems, offering a more predictive assessment of absorption and metabolic stability than previous standards. Challenges and future perspectives System complexity and ecological realism While intestinal organoids have revolutionized our ability to study epithelial biology in vitro, it is critical to acknowledge that current organoid models represent a reductionist system that captures only a subset of the complex cellular and molecular interactions present in the native intestinal tissue. Most organoid studies to date have focused on epithelial responses in isolation—a “cell-only” paradigm that, while powerful for dissecting intrinsic epithelial mechanisms, fails to recapitulate the multi-component ecosystem of the intestinal mucosa. Specifically, standard organoid cultures lack several key physiological components that are essential for faithful disease modeling. First, they are devoid of immune cells, including tissue-resident macrophages, dendritic cells, T cells, and innate lymphoid cells (ILCs), all of which play critical roles in intestinal homeostasis, inflammation, and host defense. Second, they lack vascular networks and blood flow, which are essential for nutrient delivery, waste removal, immune cell trafficking, and the systemic dissemination of inflammatory signals. Third, they are cultured under sterile conditions and thus lack the gut microbiota—a polymicrobial community of bacteria, fungi, viruses, and archaea that profoundly influences epithelial differentiation, barrier function, immune maturation, and metabolic homeostasis. Fourth, they lack the enteric nervous system (ENS), which regulates motility, secretion, and epithelial turnover through neurotransmitter signaling. Finally, they are typically cultured in static conditions and thus lack the mechanical forces (peristalsis, shear stress, stretch) and systemic signals (hormones, circulating metabolites) that shape intestinal physiology in vivo. These limitations have important implications for disease modeling. For example, IBD is driven not only by epithelial barrier dysfunction but also by dysregulated immune responses, microbial dysbiosis, and aberrant neuro-immune crosstalk. Similarly, colorectal cancer progression involves complex interactions between tumor cells, cancer-associated fibroblasts, tumor-infiltrating lymphocytes, and the tumor microbiome. Radiation enteritis, involves a cytokine storm orchestrated by immune cells, endothelial damage, and microbial translocation—none of which can be fully recapitulated in epithelial-only organoid models [62, 63]. Thus, while intestinal organoids provide invaluable insights into epithelial-intrinsic mechanisms, their translational relevance for complex diseases remains constrained by their reductionist nature. Among the missing components, the absence of gut microbiota represents a particularly critical bottleneck for disease modeling. The human gut harbors approximately 10¹⁴ bacterial cells representing over 1,000 species, which collectively encode a metabolic repertoire far exceeding that of the human genome. The microbiota is not merely a passive bystander but an active participant in intestinal physiology, contributing to nutrient metabolism (e.g., short-chain fatty acid production), immune education (e.g., regulatory T cell induction), barrier reinforcement (e.g., mucin glycosylation), and pathogen resistance (colonization resistance). Conversely, microbial dysbiosis is implicated in virtually all major intestinal diseases, including IBD, irritable bowel syndrome (IBS), colorectal cancer, and infectious enteritis [64]. Despite the clear importance of host-microbiota interactions, integrating live microbiota into organoid cultures has proven technically challenging. Standard organoid culture media contain antibiotics (e.g., penicillin-streptomycin) to prevent contamination, rendering them incompatible with bacterial co-culture. Even when antibiotics are omitted, several obstacles remain. First, many gut commensals are obligate anaerobes that cannot survive in the oxygen-rich environment of conventional organoid cultures. Second, bacteria tend to overgrow and acidify the medium, leading to organoid death within 24–48 h. Third, intestinal organoids lack the mucus layer and physical barriers that normally separate bacteria from the epithelium in vivo, leading to uncontrolled bacterial invasion and cytotoxicity. Fourth, maintaining stable polymicrobial communities (rather than single-species monocultures) in vitro is notoriously difficult, as competitive dynamics often lead to the dominance of fast-growing species. Several innovative approaches have been developed to address these challenges. Anaerobic culture systems and hypoxia chambers enable the co-culture of oxygen-sensitive commensals with intestinal organoids. Microfluidic gut-on-chip devices allow precise control of oxygen gradients, nutrient flow, and bacterial colonization, and can sustain organoid-microbiota co-cultures for extended periods. Transwell-based systems physically separate bacteria from intestinal organoids while allowing diffusion of bacterial metabolites and secreted factors. Human-microbiota-associated (HMA) intestinal organoids, in which intestinal organoids are colonized with defined microbial consortia or patient-derived fecal samples, have been used to model microbiome-dependent phenotypes such as colonization resistance and metabolite-driven signaling. Despite these advances, organoid-microbiota co-culture remains technically demanding, poorly standardized, and not yet widely adopted. Future work must prioritize the development of robust, reproducible, and scalable platforms for integrating microbiota into organoid-based disease models. Standardization of phenotypic assessment Another critical methodological challenge is the lack of standardized phenotypic assessment in intestinal organoid research. In studies of radiation injury, drug screening, toxicity testing, epithelial regeneration, and patient-derived organoid evaluation, organoid phenotypes are commonly assessed using parameters such as organoid-forming efficiency, organoid area, diameter, budding number, budding efficiency, morphology, viability, proliferation, apoptosis, lumen formation, and lineage differentiation markers. However, the definitions, imaging conditions, measurement time points, segmentation methods, and statistical thresholds used for these parameters vary considerably among studies. For example, budding number and morphology-based scoring may be influenced by culture duration, extracellular matrix composition, Matrigel batch variability, seeding density, passage number, image acquisition settings (e.g., brightfield vs. confocal microscopy), and manual observer bias. Similarly, organoid area measurements may differ depending on whether 2D projected area or 3D volumetric reconstruction is used, and whether segmentation is performed manually, semi-automatically, or using fully automated pipelines [65]. These inconsistencies limit reproducibility and make it difficult to compare results across laboratories, hindering both mechanistic understanding and translational application. This issue is particularly relevant in radiation injury models and drug assessment studies, where quantitative evaluation of epithelial damage, repair kinetics, and therapeutic response is essential. Without standardized phenotypic criteria, it becomes challenging to determine whether differences in organoid survival, budding efficiency, or regenerative capacity reflect true biological variation, experimental artifacts, or methodological inconsistencies. This lack of standardization also complicates the use of patient-derived intestinal organoids for precision medicine, as inter-laboratory variability may obscure clinically meaningful differences in drug response. Future studies should therefore prioritize the establishment of standardized reporting and quantification frameworks for intestinal organoid phenotyping. Such frameworks should include: (1). Standardized culture metadata: Clear reporting of Matrigel lot number, passage number, seeding density, culture duration, and growth factor concentrations to enable reproducibility. (2). Predefined morphological criteria: Consensus definitions for key phenotypic features such as “budding organoid,” “cystic organoid,” “viable organoid,” and “differentiated organoid.” (3). Blinded quantification: Use of blinded or randomized image analysis to reduce observer bias. (4). Automated or semi-automated image-analysis pipelines: Development and validation of standardized image segmentation and quantification tools that can be shared across laboratories. (5). Multi-parametric phenotypic scoring: Integration of morphological readouts (e.g., area, budding, circularity) with molecular endpoints (e.g., proliferation markers, apoptosis markers, differentiation markers) to provide a more comprehensive assessment of organoid phenotype. (6). Validation of AI-assisted tools: While high-content imaging and AI-assisted segmentation may improve objectivity and scalability, these tools must be rigorously validated against biologically meaningful endpoints and benchmarked across multiple datasets. Standardized phenotypic assessment will be particularly important for radiation injury models, drug evaluation studies, and patient-derived organoid biobanks, where quantitative comparison of epithelial damage, repair, and therapeutic response is essential for translational applications. Efforts to establish community-wide standards, such as those initiated by the International Society for Stem Cell Research (ISSCR) and the European Organoid Society, should be supported and expanded to include intestinal organoid-specific guidelines. Limitations Although the Web of Science Core Collection provides standardized citation records and is widely used in bibliometric studies, the exclusive use of this database may introduce selection bias. In particular, WoS has relatively limited coverage of non-English journals, regional journals, and newly established journals. Therefore, research contributions from certain countries or regions, especially those outside Europe and North America, may be underestimated. This limitation should be considered when interpreting the global distribution, collaboration networks, and developmental trends of intestinal organoid research. Conclusion This bibliometric study provides a comprehensive, data-driven panorama of intestinal organoid research over the past four decades (Fig. 8). Our analysis yields several key insights: (1) The field has experienced exponential growth since the landmark discovery of Lgr5 + stem cells, with the USA leading in output volume while the Netherlands dominates in citation impact per paper, underscoring the lasting value of foundational work. (2) Research collaboration is globally interconnected but regionally patterned, with Europe showing higher international co-authorship rates than East Asia. (3) The intellectual structure is built upon two methodological pillars: the adult stem cell (ASC) approach pioneered by Clevers and Sato, and the pluripotent stem cell (PSC) approach advanced by Spence and Wells. (4) Research hotspots have evolved dynamically from basic culture establishment (2009–2016) to disease modeling and biobanking (2017–2020), and are now converging with bioengineering toward organ-on-a-chip systems and single-cell multi-omics (2021-present). This study has several limitations. First, the data were sourced exclusively from the Web of Science, potentially excluding relevant studies indexed in other databases (e.g., Scopus, PubMed). Second, bibliometric analysis inherently carries a citation lag, meaning the most recent publications and emerging trends may not be fully reflected in citation metrics. Third, the analysis of keywords and themes depends on authors’ choice of terminology, which may introduce bias. Based on the detected trends, future research should focus on: (1) Standardization and Automation: Addressing the technical complexity highlighted by the prominence of JoVE, through developing robust, automated protocols. (2) System Complexity: Integrating vascularization, immune cells, and the microbiome into next-generation “gut-on-a-chip” models to better mimic physiology. (3) Data Integration: Leveraging single-cell sequencing and AI to build predictive “digital twins” of patient-derived intestinal organoids for personalized therapy. (4) Policy Encouragement: For regions like East Asia, fostering greater international collaboration could be a strategic pathway to enhance global research impact. Fig. 8Conceptual workflow and major applications of intestinal organoids Conceptual workflow and major applications of intestinal organoids